Literature DB >> 1185009

Experimental disseminated candidiasis. II. Administration of glucocorticosteroids, susceptibility to infection, and immunity.

D L Hurley, J E Balow, A S Fauci.   

Abstract

A model of experimental disseminated candidiasis in inbred guinea pigs was used for study of the effects of both short-acting and long-acting glucocorticosteroid administration on the susceptibility to infection, the development of in vivo and in vitro parameters of cell-mediated immunity, and the expression of already established Candida-specific, cell-mediated immunity. Results revealed that long-acting glucocorticosteroids markedly potentiated infection, increasing mortality and suppressing already established cellular immune parameters. The development of cellular immunity to Candida was not impaired. Short-acting glucocorticosteroids, however, did not potentiate infection, and they affected neither the development nor the expression of immune parameters.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185009     DOI: 10.1093/infdis/132.4.393

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Immunity to Candida albicans.

Authors:  T J Rogers; E Balish
Journal:  Microbiol Rev       Date:  1980-12

2.  Regulation of innate immune response to Candida albicans infections by αMβ2-Pra1p interaction.

Authors:  Dmitry A Soloviev; Samir Jawhara; William A Fonzi
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

3.  Pulmonary candidiasis in cystic fibrosis.

Authors:  B M Jenner; L I Landau; P D Phelan
Journal:  Arch Dis Child       Date:  1979-07       Impact factor: 3.791

4.  Systemic candidiasis in mice treated with prednisolone and amphotericin B. 1. Morbidity, mortality and inflammatory reaction.

Authors:  W Blyth; G E Stewart
Journal:  Mycopathologia       Date:  1978-12-29       Impact factor: 2.574

5.  Effects of ovarian hormones on manifestation of purulent endometritis in rat uteruses infected with Escherichia coli.

Authors:  Y Nishikawa; T Baba
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.